TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17556718

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) for 4 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: No treatment (Control) for 4 months
Number of subjects: 24
Study: 15218357

Group type: EXPERIMENTAL
Intervention: Epirubicin and Cyclophosphamide (EC)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Paclitaxel (ET)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Decrease of HER-2/neu ECD levels after three courses of therapy
Number of subjects: 103
Study: 11345180

Group type: EXPERIMENTAL
Intervention: Extensive protein hydrolysate preterm formula (EH)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Partial protein hydrolysate preterm formula (PH)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard preterm formula (SF)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Fortified breast milk (FBM)
Number of subjects: 61
Study: 9641650

Group type: EXPERIMENTAL
Intervention: Lansoprazole alone
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lansoprazole and amoxycillin
Number of subjects: 23
Study: 7743368

Group type: EXPERIMENTAL
Intervention: Serum levels of nitrite/nitrate (NO2/NO3) in septic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of NO2/NO3 with tumor necrosis factor alpha
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of NO2/NO3 with interleukin 6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Body core temperature correlation with NO2/NO3 levels
Number of subjects: 0
Study: 2700362

Group type: EXPERIMENTAL
Intervention: PT-01
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: S + A (PT-01 treatment combined with scaling)
Number of subjects: 0
Study: 792640

Group type: EXPERIMENTAL
Intervention: Mazindol (AN 448)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (placebo or no treatment)
Number of subjects: 28
Study: 30347119

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention delivered by text message
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 27989399

Group type: EXPERIMENTAL
Intervention: End-of-life communication intervention
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 376
Study: 25935412

Group type: EXPERIMENTAL
Intervention: Non-smoker
Number of subjects: 1374

Group type: COMPARATOR
Intervention: Smoker
Number of subjects: 1374
Study: 23442897

Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: General psychiatric management
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Baseline number of suicide attempts
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Severity of childhood sexual abuse
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Number of hospitalizations in the 4 months prior to study entry
Number of subjects: 180
Study: 21402982

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of autologous plasmin enzyme (APE), 0.2 mL
Number of subjects: 8
Study: 18945594

Group type: EXPERIMENTAL
Intervention: Ertapenem
Number of subjects: 403

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 403
Study: 17038056

Group type: EXPERIMENTAL
Intervention: Normal dose of 1% chlorhexidine gel
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Low dose of chlorhexidine gel and whitening dentifrice
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard fluoride paste
Number of subjects: 157
Study: 12921007

Group type: EXPERIMENTAL
Intervention: lifestyle physical activity intervention (group-based)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: lifestyle physical activity intervention (telephone and mail-delivered)
Number of subjects: 244
Study: 11034509

Group type: EXPERIMENTAL
Intervention: Caudal anaesthesia with 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standardized general anaesthetic (control group)
Number of subjects: 60
Study: 9068264

Group type: COMPARATOR
Intervention: 50 mg/day atenolol
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 200 mg/day celiprolol
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 80 mg/day isosorbide dinitrate
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: celiprolol
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 56
Study: 8446440

Group type: EXPERIMENTAL
Intervention: Epidural morphine (4 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study: 3462014

Group type: EXPERIMENTAL
Intervention: Cladosporium herbarum inhalation (1:100000, 1:10000, 1:1000, 1:100 w/v)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline inhalation
Number of subjects: 5

Group type: COMPARATOR
Intervention: Histamine inhalation (0.3, 0.6, 1.2, 2.4 mg/ml)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cladosporium herbarum inhalation
Number of subjects: 5

Group type: COMPARATOR
Intervention: Histamine inhalation
Number of subjects: 5
Study: 31694978

Group type: EXPERIMENTAL
Intervention: Atypical Anorexia Nervosa (AAN)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Lower heart rate (HR)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Lower serum phosphorus
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Weight and menstrual history
Number of subjects: 116
Study: 28857203

Group type: EXPERIMENTAL
Intervention: Total pulpectomy (TP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Partial pulpectomy (PP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Pulpotomy (P)
Number of subjects: 66
Study: 26474268

Group type: EXPERIMENTAL
Intervention: Informational video presentation (group V, N=21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care (verbal information, group C, N=21)
Number of subjects: 42
Study: 24605292

Group type: EXPERIMENTAL
Intervention: Pre-patient training program by cadaver dissection
Number of subjects: 5

Group type: COMPARATOR
Intervention: Step-by-step training model on real patients
Number of subjects: 5
Study: 22124840

Group type: EXPERIMENTAL
Intervention: Open donor nephrectomy
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Right-sided transabdominal donor nephrectomy
Number of subjects: 51
Study: 20229169

Group type: EXPERIMENTAL
Intervention: 3 g PSK plus 300 mg UFT
Number of subjects: 21

Group type: COMPARATOR
Intervention: 300 mg UFT alone (control)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: PSK group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All patients analyzed
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: PSK + UFT group
Number of subjects: 21
Study: 17660032

Group type: EXPERIMENTAL
Intervention: Oral administration of 800 IU of vitamin E alpha daily
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 15979439

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting TAXUS stent
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bare metal control stent
Number of subjects: 61
Study: 12787300

Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: fexofenadine 30 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: cetirizine vs fexofenadine
Number of subjects: 15
Study: 10383105

Group type: EXPERIMENTAL
Intervention: vancomycin/ceftriaxone
Number of subjects: 112

Group type: COMPARATOR
Intervention: cefazolin
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: vancomycin/gentamicin
Number of subjects: 112

Group type: COMPARATOR
Intervention: cefazolin/gentamicin
Number of subjects: 112
Study: 8876706

Group type: EXPERIMENTAL
Intervention: 320 mg Permixon
Number of subjects: 1098

Group type: COMPARATOR
Intervention: 5 mg finasteride
Number of subjects: 1098
Study: 1850811

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy after initial resection
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy followed by resection
Number of subjects: 81

Group type: COMPARATOR
Intervention: Combination of chemotherapy and radiotherapy (non-surgical patients)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Surgical resection (overall surgical patients)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Postoperative chemotherapy only (for stage III patients)
Number of subjects: 81
Study: 6218789

Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride, 0.05 mg, orally twice daily for two weeks
Number of subjects: 0
Study: 30332920

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity testing before chemotherapy and during febrile neutropenia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison to a control group of 30 age and sex matched patients with obesity
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity testing in patients with documented site of infection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall assessment of insulin sensitivity and hospitalization outcome
Number of subjects: 30
Study: 30280582

Group type: EXPERIMENTAL
Intervention: Written consent
Number of subjects: 2027

Group type: COMPARATOR
Intervention: Notification after enrollment
Number of subjects: 2027

Group type: EXPERIMENTAL
Intervention: Brief verbal consent
Number of subjects: 2027

Group type: EXPERIMENTAL
Intervention: Cost information
Number of subjects: 2027
Study: 26810999

Group type: EXPERIMENTAL
Intervention: Daily intravenous human albumin solution infusions for up to 14 days or until discharge, based on serum albumin levels.
Number of subjects: 80
Study: 24495599

Group type: EXPERIMENTAL
Intervention: Peer support
Number of subjects: 46

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 46
Study: 22218376

Group type: EXPERIMENTAL
Intervention: Single intra-articular injection of 2.5 mL of low-molecular-weight, non-cross-linked hyaluronic acid
Number of subjects: 64

Group type: COMPARATOR
Intervention: Single intra-articular injection of 2.5 mL of normal saline solution (placebo)
Number of subjects: 64
Study: 20404227

Group type: EXPERIMENTAL
Intervention: Intraoperative dermoscopy
Number of subjects: 152

Group type: COMPARATOR
Intervention: Clinical evaluation
Number of subjects: 152

Group type: COMPARATOR
Intervention: Evaluation according to the ABCDEF rule
Number of subjects: 152

Group type: COMPARATOR
Intervention: Dermoscopy of the nail plate
Number of subjects: 152
Study: 17380530

Group type: EXPERIMENTAL
Intervention: Yttrium 90 ibritumomab tiuxetan
Number of subjects: 211
Study: 15673841

Group type: EXPERIMENTAL
Intervention: Modified constraint-induced therapy (mCIT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional rehabilitation (TR)
Number of subjects: 10
Study: 11864865

Group type: EXPERIMENTAL
Intervention: LCP-supplemented formula
Number of subjects: 65

Group type: COMPARATOR
Intervention: Formula without LCPs
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 65
Study: 10534462

Group type: EXPERIMENTAL
Intervention: Supervised exercise program for 8 weeks followed by jogging, cycling, or swimming guided by target heart rate (n=315)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Control group maintaining normal routines without regular exercise (n=319)
Number of subjects: 651
Study: 7777350

Group type: EXPERIMENTAL
Intervention: Canalith repositioning maneuver with mastoid vibration (n=27)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Canalith repositioning maneuver without mastoid vibration (n=10)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment, n=23)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Canalith repositioning maneuver with mastoid vibration (in a review of 67 patients)
Number of subjects: 60
Study: 2407144

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (bupivacaine 0.25% and fentanyl 2 micrograms/ml, infused at 6-10 ml/h for 76:1.45 h)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control (standard general anesthesia with piritramid for postoperative pain relief)
Number of subjects: 214
Study: 7437747

Group type: EXPERIMENTAL
Intervention: Gas-powered jet injection
Number of subjects: 10

Group type: COMPARATOR
Intervention: Needle and syringe
Number of subjects: 10
Study: 30927229

Group type: EXPERIMENTAL
Intervention: Parent-report questionnaire (Swanson, Nolan and Pelham Questionnaire‐IV; SNAP‐IV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinical judgment (semi-structured parent interview)
Number of subjects: 0
Study: 28614910

Group type: EXPERIMENTAL
Intervention: TP53 mutation
Number of subjects: 265

Group type: COMPARATOR
Intervention: Wild-type TP53
Number of subjects: 265
Study: 27476252

Group type: EXPERIMENTAL
Intervention: Intramuscular oxytocin
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intravenous oxytocin
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intravenous traditional oxytocin infusion
Number of subjects: 66

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 66
Study: 25110677

Group type: EXPERIMENTAL
Intervention: Testosterone therapy (1 mL of testosterone enanthate 250 mg/mL) once every four weeks for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (1 mL of 0.9% wt/vol NaCl) once every four weeks for 12 weeks
Number of subjects: 50
Study: 22392565

Group type: EXPERIMENTAL
Intervention: Reduced-dose chemotherapy (elimination of 2 induction drugs and 3 months of maintenance therapy from the standard regimen)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard regimen from CCG 2891 (DCTER)
Number of subjects: 132
Study: 18809309

Group type: EXPERIMENTAL
Intervention: Proteoheparan sulfate coated, hydrophobic silica surface biosensor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pattern analysis of biomarker molecules from blood samples
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined use of both biosensors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimized therapy decision based on diagnostic tools
Number of subjects: 0
Study: 17315527

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI) of glargine
Number of subjects: 32
Study: 15148453

Group type: EXPERIMENTAL
Intervention: Polymyxin B-immobilized fiber (PMX-F) treatment
Number of subjects: 12
Study: 11691759

Group type: COMPARATOR
Intervention: School based intervention including teacher training, modification of school meals, and development of school action plans.
Number of subjects: 634

Group type: COMPARATOR
Intervention: School based intervention
Number of subjects: 634
Study: 9478091

Group type: EXPERIMENTAL
Intervention: Chlorfenvinphos exposure
Number of subjects: 41
Study: 7702797

Group type: EXPERIMENTAL
Intervention: Low-normal blood pressure group
Number of subjects: 283

Group type: COMPARATOR
Intervention: High-normal blood pressure group
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 283
Study: 3301155

Group type: EXPERIMENTAL
Intervention: Nicardipine (20 or 40 mg t.i.d.)
Number of subjects: 7
Study: 31321536

Group type: EXPERIMENTAL
Intervention: 3D HD laparoscopic system
Number of subjects: 120

Group type: COMPARATOR
Intervention: 4K laparoscopic system
Number of subjects: 120
Study: 28927647

Group type: EXPERIMENTAL
Intervention: Use of an osteotome in addition to standard technique to preserve a bone island anterior to the tibial attachment of the PCL
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard tibial resection without the use of an osteotome (control group)
Number of subjects: 60
Study: 28245853

Group type: EXPERIMENTAL
Intervention: Standardised, individualised or physiotherapist-supervised neuromuscular shoulder exercise programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care (self-managed shoulder exercise programme)
Number of subjects: 80
Study: 26129996

Group type: EXPERIMENTAL
Intervention: Culturally Adapted Cognitive-Behavioral Therapy (CA-CBT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 50
Study: 23836044

Group type: EXPERIMENTAL
Intervention: Systemic antibiotics (AB) - amoxicillin and metronidazole three times a day for 7 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) - two applications on the day of SRP and at follow-up after 7 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison between AB and PDT
Number of subjects: 36
Study: 21185118

Group type: EXPERIMENTAL
Intervention: Pregabalin (50-200mg t.i.d.)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 103
Study: 18503851

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 55

Group type: COMPARATOR
Intervention: Normal saline solution (Control)
Number of subjects: 55
Study: 12622856

Group type: EXPERIMENTAL
Intervention: Braun Oral-B 3D Plaque Remover
Number of subjects: 35

Group type: COMPARATOR
Intervention: Butler GUM 311
Number of subjects: 35
Study: 9477048

Group type: EXPERIMENTAL
Intervention: 200 microg OTFC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 microg OTFC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 800 microg OTFC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1,600 microg OTFC
Number of subjects: 12
Study: 8675721

Group type: EXPERIMENTAL
Intervention: Polydipsic patients with marked stereotypies
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Polydipsic patients with no history of stereotypy
Number of subjects: 3

Group type: COMPARATOR
Intervention: Nonpolydipsic patient
Number of subjects: 3
Study: 2243674

Group type: EXPERIMENTAL
Intervention: Ketorolac ophthalmic solution (NSAID)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 80526

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29621113

Group type: EXPERIMENTAL
Intervention: Repeated Power Group (RPG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 20
Study: 28796316

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) PMN-'low'
Number of subjects: 18
Study: 26154185

Group type: EXPERIMENTAL
Intervention: Nociception Level (NoL) index during moderate noxious stimulation (skin incision)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nociception Level (NoL) index during intense noxious stimulation (intubation)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) during moderate noxious stimulation (skin incision)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP) during moderate noxious stimulation (skin incision)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) during intense noxious stimulation (intubation)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP) during intense noxious stimulation (intubation)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Receiver Operating Characteristic (ROC) curve for ΔNoL
Number of subjects: 72
Study: 23657629

Group type: EXPERIMENTAL
Intervention: Melanoma vaccine in incomplete Freund's adjuvant (IFA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Incomplete Freund's adjuvant (IFA) only
Number of subjects: 45
Study: 21177791

Group type: EXPERIMENTAL
Intervention: Daily transdermal DHT gel
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 31
Study: 19725341

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block with 0.45% ropivacaine at a dosage of 0.3 mL/kg (maximum dose, 30 mL)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no block performed)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block
Number of subjects: 41
Study: 17623694

Group type: EXPERIMENTAL
Intervention: Iclaprim (AR-100) 1.6 mg/kg intravenous infusion
Number of subjects: 0
Study: 14690867

Group type: EXPERIMENTAL
Intervention: Care consultation (multi-component telephone intervention) in addition to usual managed care services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual managed care services
Number of subjects: 0
Study: 11222075

Group type: EXPERIMENTAL
Intervention: Computer-aided detection (CAD) system
Number of subjects: 106

Group type: COMPARATOR
Intervention: Mammographers without CAD
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Mammographers with CAD
Number of subjects: 106
Study: 9605364

Group type: EXPERIMENTAL
Intervention: Score I (risk score for postoperative vomiting)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Score II (new risk score for postoperative vomiting)
Number of subjects: 1091
Study: 7812305

Group type: EXPERIMENTAL
Intervention: Fiuggi water (more than 1500 ml/die) for 7 and 14 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: Fiuggi water (less than 1500 ml/die) for 7 and 14 days
Number of subjects: 200
Study: 2978287

Group type: EXPERIMENTAL
Intervention: Protein meal (1-1.5 g of protein/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Carbohydrate meal (similar caloric, sodium, and potassium content)
Number of subjects: 10
Study: 30230088

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CBA)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 210
Study: 28260593

Group type: EXPERIMENTAL
Intervention: Seven-point grading scale (autumn semester)
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Pass/fail approach (spring semester)
Number of subjects: 1037

Group type: COMPARATOR
Intervention: International students (control group)
Number of subjects: 1037
Study: 25556038

Group type: EXPERIMENTAL
Intervention: MRI group (177 patients)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (89 patients)
Number of subjects: 266
Study: 23639612

Group type: EXPERIMENTAL
Intervention: Biomarker-based diagnostic strategy (aspergillus galactomannan and PCR)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard diagnostic strategy (culture and histology)
Number of subjects: 240
Study: 20694508

Group type: EXPERIMENTAL
Intervention: Family Cognitive-Behavioral Therapy (FCBT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Individual Cognitive-Behavioral Therapy (ICBT)
Number of subjects: 50
Study: 19652948

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 500

Group type: COMPARATOR
Intervention: Hydrocortisone
Number of subjects: 500